Company Revenue

The company rebounded nicely in 3Q22 with mid-single digit growth when excluding foreign currency headwinds....

In this edition of our mid-tier player profiles, we focus on three spine players in the top ten that are...

The company's 1H22 revenue declined in the low single digits due to currency pressures but it expanded market access by...

The company grew in the mid-teens for 2Q22, driven by strong COVID recoveries in most European countries along with the...

Despite share gains in its U.S. core spine products, Medtronic declined in the mid-single digits due to VBP in China...

The company grew in the high teens for 1H22 but lowered its full-year guidance due to OR staffing headwinds and...

The company grew in the high single digits for its fiscal year 2022, driven in part by gains in its...

The company grew in the high teens for 1H22, driven by an expanded salesforce and further adoption of the NextAR...

The company grew +45% in 2Q22 by driving increased market penetration and product utilization among its surgeon population....

The company grew in the mid-teens for the second quarter of 2022, attaining the most active surgeons in company history....